rs78822624

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001849.4(COL6A2):​c.714+9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0468 in 1,611,360 control chromosomes in the GnomAD database, including 2,028 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.035 ( 133 hom., cov: 32)
Exomes 𝑓: 0.048 ( 1895 hom. )

Consequence

COL6A2
NM_001849.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.558

Publications

2 publications found
Variant links:
Genes affected
COL6A2 (HGNC:2212): (collagen type VI alpha 2 chain) This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]
COL6A2 Gene-Disease associations (from GenCC):
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Ullrich congenital muscular dystrophy 1B
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: G2P
  • Bethlem myopathy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myosclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 21-46112586-C-T is Benign according to our data. Variant chr21-46112586-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 93959.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0516 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A2NM_001849.4 linkc.714+9C>T intron_variant Intron 3 of 27 ENST00000300527.9 NP_001840.3
COL6A2NM_058174.3 linkc.714+9C>T intron_variant Intron 3 of 27 ENST00000397763.6 NP_478054.2
COL6A2NM_058175.3 linkc.714+9C>T intron_variant Intron 3 of 27 NP_478055.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A2ENST00000300527.9 linkc.714+9C>T intron_variant Intron 3 of 27 1 NM_001849.4 ENSP00000300527.4
COL6A2ENST00000397763.6 linkc.714+9C>T intron_variant Intron 3 of 27 5 NM_058174.3 ENSP00000380870.1

Frequencies

GnomAD3 genomes
AF:
0.0351
AC:
5330
AN:
151990
Hom.:
133
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0101
Gnomad AMI
AF:
0.0540
Gnomad AMR
AF:
0.0185
Gnomad ASJ
AF:
0.0332
Gnomad EAS
AF:
0.000971
Gnomad SAS
AF:
0.0255
Gnomad FIN
AF:
0.0623
Gnomad MID
AF:
0.0510
Gnomad NFE
AF:
0.0530
Gnomad OTH
AF:
0.0273
GnomAD2 exomes
AF:
0.0384
AC:
9347
AN:
243458
AF XY:
0.0400
show subpopulations
Gnomad AFR exome
AF:
0.00927
Gnomad AMR exome
AF:
0.0155
Gnomad ASJ exome
AF:
0.0316
Gnomad EAS exome
AF:
0.000219
Gnomad FIN exome
AF:
0.0715
Gnomad NFE exome
AF:
0.0532
Gnomad OTH exome
AF:
0.0342
GnomAD4 exome
AF:
0.0481
AC:
70154
AN:
1459252
Hom.:
1895
Cov.:
34
AF XY:
0.0477
AC XY:
34645
AN XY:
725936
show subpopulations
African (AFR)
AF:
0.00882
AC:
295
AN:
33454
American (AMR)
AF:
0.0157
AC:
701
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.0311
AC:
811
AN:
26110
East Asian (EAS)
AF:
0.000151
AC:
6
AN:
39686
South Asian (SAS)
AF:
0.0315
AC:
2715
AN:
86234
European-Finnish (FIN)
AF:
0.0715
AC:
3678
AN:
51422
Middle Eastern (MID)
AF:
0.0460
AC:
264
AN:
5740
European-Non Finnish (NFE)
AF:
0.0533
AC:
59262
AN:
1111578
Other (OTH)
AF:
0.0401
AC:
2422
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
4210
8421
12631
16842
21052
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2150
4300
6450
8600
10750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0350
AC:
5327
AN:
152108
Hom.:
133
Cov.:
32
AF XY:
0.0351
AC XY:
2610
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.0100
AC:
417
AN:
41512
American (AMR)
AF:
0.0184
AC:
281
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0332
AC:
115
AN:
3466
East Asian (EAS)
AF:
0.000974
AC:
5
AN:
5136
South Asian (SAS)
AF:
0.0261
AC:
126
AN:
4822
European-Finnish (FIN)
AF:
0.0623
AC:
661
AN:
10602
Middle Eastern (MID)
AF:
0.0479
AC:
14
AN:
292
European-Non Finnish (NFE)
AF:
0.0530
AC:
3602
AN:
67966
Other (OTH)
AF:
0.0270
AC:
57
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
263
526
790
1053
1316
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0486
Hom.:
290
Bravo
AF:
0.0300
Asia WGS
AF:
0.00837
AC:
29
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
Aug 29, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 16, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 14, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Myosclerosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Collagen 6-related myopathy Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Bethlem myopathy 1A Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
8.7
DANN
Benign
0.94
PhyloP100
0.56
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78822624; hg19: chr21-47532500; API